Intravenous immunoglobulins in neurological diseases Uwe K. ZettlEilhard Mix EDITORIAL Pages: v1 - v1
Immunoglobulins—Basic considerations Eilhard MixRobert GoertschesUwe K. Zett OriginalPaper Pages: v9 - v17
Basic principles of intravenous immunoglobulin (IVIg) treatment Martin StangelRefik Pul OriginalPaper Pages: v18 - v24
Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects Marinos C. Dalakas OriginalPaper Pages: v25 - v32
Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes Raymond Voltz OriginalPaper Pages: v33 - v38
Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders Andreas SteinbrecherPeter Berlit OriginalPaper Pages: v39 - v49
Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis Ales DudesekUwe K. Zettl OriginalPaper Pages: v50 - v58
Therapy of immune neuropathies with intravenous immunoglobulins Ralf GoldBernd C. Kieseier OriginalPaper Pages: v59 - v63
Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis) Dieter Pongratz OriginalPaper Pages: v64 - v65
Rare indications of IVIG therapy in neurological diseases based on case reports and small studies Hayrettin Tumani OriginalPaper Pages: v66 - v69
Intravenous immunoglobulin therapy in neurological diseases during pregnancy Isabel RingelUwe K. Zettl OriginalPaper Pages: v70 - v74
Adverse effects of treatment with intravenous immunoglobulins for neurological diseases Matthias WittstockUwe K. Zettl OriginalPaper Pages: v75 - v79
IVIG therapy in neurological disorders of childhood Juan J. ArchelosFranz Fazekas OriginalPaper Pages: v80 - v86
